US Bancorp’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.54K | Sell |
205
-1,635
| -89% | -$78.5K | ﹤0.01% | 3458 |
|
|
2026
Q1 | $95.1K | Buy |
1,840
+63
| +4% | +$3.21K | ﹤0.01% | 2413 |
|
|
2025
Q4 | $88.3K | Sell |
1,777
-618
| -26% | -$30K | ﹤0.01% | 2444 |
|
|
2025
Q3 | $114K | Sell |
2,395
-3,170
| -57% | -$128K | ﹤0.01% | 2289 |
|
|
2025
Q2 | $175K | Sell |
5,565
-596
| -10% | -$19.1K | ﹤0.01% | 2105 |
|
|
2025
Q1 | $202K | Buy |
6,161
+104
| +2% | +$3.69K | ﹤0.01% | 1992 |
|
|
2024
Q4 | $219K | Buy |
6,057
+18
| +0.3% | +$634 | ﹤0.01% | 1985 |
|
|
2024
Q3 | $188K | Buy |
6,039
+76
| +1% | +$2.37K | ﹤0.01% | 2062 |
|
|
2024
Q2 | $160K | Sell |
5,963
-88
| -1% | -$2.55K | ﹤0.01% | 2112 |
|
|
2024
Q1 | $206K | Buy |
6,051
+453
| +8% | +$13.5K | ﹤0.01% | 1992 |
|
|
2023
Q4 | $162K | Sell |
5,598
-68
| -1% | -$1.8K | ﹤0.01% | 2113 |
|
|
2023
Q3 | $156K | Sell |
5,666
-385
| -6% | -$11.7K | ﹤0.01% | 1940 |
|
|
2023
Q2 | $182K | Sell |
6,051
-218
| -3% | -$7.63K | ﹤0.01% | 1915 |
|
|
2023
Q1 | $227K | Buy |
6,269
+923
| +17% | +$35.5K | ﹤0.01% | 1802 |
|
|
2022
Q4 | $191K | Sell |
5,346
-513
| -9% | -$17.8K | ﹤0.01% | 1890 |
|
|
2022
Q3 | $198K | Sell |
5,859
-835
| -12% | -$27.2K | ﹤0.01% | 1858 |
|
|
2022
Q2 | $194K | Sell |
6,694
-2,879
| -30% | -$82.5K | ﹤0.01% | 1902 |
|
|
2022
Q1 | $309K | Sell |
9,573
-3,077
| -24% | -$94.3K | ﹤0.01% | 1748 |
|
|
2021
Q4 | $369K | Sell |
12,650
-266
| -2% | -$8.07K | ﹤0.01% | 1685 |
|
|
2021
Q3 | $344K | Sell |
12,916
-769
| -6% | -$20.6K | ﹤0.01% | 1701 |
|
|
2021
Q2 | $421K | Buy |
13,685
+619
| +5% | +$19K | ﹤0.01% | 1638 |
|
|
2021
Q1 | $342K | Buy |
13,066
+1,784
| +16% | +$49.9K | ﹤0.01% | 1691 |
|
|
2020
Q4 | $284K | Sell |
11,282
-1,664
| -13% | -$35.8K | ﹤0.01% | 1719 |
|
|
2020
Q3 | $269K | Sell |
12,946
-3,822
| -23% | -$86.7K | ﹤0.01% | 1635 |
|
|
2020
Q2 | $399K | Sell |
16,768
-3,501
| -17% | -$77.4K | ﹤0.01% | 1419 |
|
|
2020
Q1 | $365K | Sell |
20,269
-527
| -3% | -$11.1K | ﹤0.01% | 1378 |
|
|
2019
Q4 | $493K | Sell |
20,796
-5,802
| -22% | -$141K | ﹤0.01% | 1383 |
|
|
2019
Q3 | $732K | Sell |
26,598
-5,638
| -17% | -$167K | ﹤0.01% | 1188 |
|
|
2019
Q2 | $1.07M | Sell |
32,236
-8,018
| -20% | -$275K | ﹤0.01% | 1039 |
|
|
2019
Q1 | $1.41M | Buy |
40,254
+4,268
| +12% | +$159K | ﹤0.01% | 924 |
|
|
2018
Q4 | $1.2M | Buy |
35,986
+7,267
| +25% | +$312K | ﹤0.01% | 929 |
|
|
2018
Q3 | $1.45M | Buy |
28,719
+4,846
| +20% | +$239K | ﹤0.01% | 933 |
|
|
2018
Q2 | $1.43M | Sell |
23,873
-917
| -4% | -$47.5K | ﹤0.01% | 937 |
|
|
2018
Q1 | $1.14M | Sell |
24,790
-2,902
| -10% | -$121K | ﹤0.01% | 1025 |
|
|
2017
Q4 | $1.1M | Sell |
27,692
-4,391
| -14% | -$174K | ﹤0.01% | 1049 |
|
|
2017
Q3 | $1.28M | Sell |
32,083
-5,939
| -16% | -$257K | ﹤0.01% | 974 |
|
|
2017
Q2 | $1.64M | Sell |
38,022
-2,968
| -7% | -$106K | 0.01% | 848 |
|
|
2017
Q1 | $1.28M | Sell |
40,990
-9,108
| -18% | -$244K | ﹤0.01% | 958 |
|
|
2016
Q4 | $1.26M | Sell |
50,098
-4,410
| -8% | -$98.5K | ﹤0.01% | 946 |
|
|
2016
Q3 | $1.35M | Sell |
54,508
-5,296
| -9% | -$120K | 0.01% | 884 |
|
|
2016
Q2 | $1.22M | Buy |
59,804
+1,205
| +2% | +$21.4K | ﹤0.01% | 906 |
|
|
2016
Q1 | $893K | Sell |
58,599
-7,985
| -12% | -$104K | ﹤0.01% | 1037 |
|
|
2015
Q4 | $894K | Buy |
66,584
+34,405
| +107% | +$532K | ﹤0.01% | 1019 |
|
|
2015
Q3 | $451K | Buy |
32,179
+28,441
| +761% | +$529K | ﹤0.01% | 1340 |
|
|
2015
Q2 | $63K | Sell |
3,738
-8,027
| -68% | -$114K | ﹤0.01% | 2410 |
|
|
2015
Q1 | $142K | Hold |
11,765
| – | – | ﹤0.01% | 1942 |
|
|
2014
Q4 | $98K | Buy |
11,765
+715
| +6% | +$6.01K | ﹤0.01% | 2155 |
|
|
2014
Q3 | $96K | Hold |
11,050
| – | – | ﹤0.01% | 2124 |
|
|
2014
Q2 | $121K | Hold |
11,050
| – | – | ﹤0.01% | 2034 |
|
|
2014
Q1 | $99K | Hold |
11,050
| – | – | ﹤0.01% | 2119 |
|
|
2013
Q4 | $83K | Hold |
11,050
| – | – | ﹤0.01% | 2201 |
|
|
2013
Q3 | $81K | Buy |
+11,050
| New | +$74.2K | ﹤0.01% | 2133 |
|
Other funds holding SUPN
AC
NAMI
SIMG
US Bancorp's SUPN Position: Q2 2026 in Review
US Bancorp reduced its Supernus Pharmaceuticals (SUPN) stake by 89% in Q2 2026, selling an estimated $78.5K and leaving 205 shares worth $9.54K. The position accounts for ﹤0.01% of the portfolio, ranked #3458.
US Bancorp first reported a position in SUPN in Q3 2013 and has held it in 52 quarters since. The position peaked at $1.64M in Q2 2017. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- US Bancorp held 205 shares of Supernus Pharmaceuticals worth $9.54K as of Q2 2026.
- US Bancorp sold 1,635 Supernus Pharmaceuticals shares in Q2 2026, an estimated $78.5K.
- Supernus Pharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3458 holding.
- US Bancorp first reported a position in Supernus Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
- US Bancorp's Supernus Pharmaceuticals position peaked at $1.64M in Q2 2017.
- 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.